1
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
Condition(s):Paroxysmal Atrial FibrillationLast Updated:April 28, 2022Recruiting
Flecainide Acetate: 20 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
Condition(s):Paroxysmal Atrial Fibrillation (PAF)Last Updated:January 14, 2022Active, not recruiting
3
To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
Condition(s):Atrial FibrillationLast Updated:February 7, 2022Completed
4
Flecainide in Treating Patients With Chronic Neuropathic Pain
Condition(s):PainLast Updated:January 28, 2010Completed
5
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia
Condition(s):Patent Foramen Ovale; Atrial Fibrillation; Cryptogenic StrokeLast Updated:July 25, 2022Enrolling by invitation
6
Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
Condition(s):Ventricular Premature Complexes; Outflow Tract; CarvedilolLast Updated:July 18, 2018Unknown status
7
Pilot Randomized Trial With Flecainide in ARVC Patients
Condition(s):Arrhythmogenic Right Ventricular CardiomyopathyLast Updated:September 10, 2021Recruiting
8
Acupuncture in Persistent Atrial Fibrillation
Condition(s):Persistent Atrial FibrillationLast Updated:April 10, 2014Unknown status
9
Premature Ventricular Contractions (PVCs) and Blood Pressure Control
Condition(s):Ventricular Premature Complexes; Blood PressureLast Updated:February 22, 2019Terminated
10
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Condition(s):Catecholaminergic Polymorphic Ventricular TachycardiaLast Updated:June 14, 2017Completed